Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07571538 · ClinicalTrials.gov registry record · NA
VisionApp - Ghosting
A NA study, sponsored by Indiana University.
- Recruiting
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT07571538 is a NA study that is actively recruiting participants, run by Indiana University. The registered enrollment target is 12 participants.
The verdict
NCT07571538, a NA study, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
Recent Android mobile device technology is available which allows user-measured refractive error and reading add power. This technology could be quite useful to the clinical and research community. The current study aims to evaluate the accuracy, repeatability, and reproducibility of one such technology by VisionApp, specifically with regard to ghosting vision. VisionApp is an app which runs on a smartphone or other device which uses the distance between the user's face and the phone to determine refractive error, while the user looks at different targets (lines, letters, words, etc).
Interventions
- DEVICE Proclear 1 Day Contact Lens
- DEVICE MyDay Contact Lens
- DEVICE NaturalVue Contact Lens
- DEVICE MiSight 1 Day Contact Lens
- DEVICE Investigational Contact Lens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2025-10-10 |
| Est. Completion | 2026-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07571538
The ClinicalTrials.gov registry entry for NCT07571538 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Proclear 1 Day Contact Lens is the first listed.
NCT07571538 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07571538 about?
NCT07571538 is a clinical study titled "VisionApp - Ghosting". Recent Android mobile device technology is available which allows user-measured refractive error and reading add power. This technology could be quite useful to the clinical and research community. The current study aims to evaluate the accuracy, repeatability, and reproducibility of one such techno...
What is the current status of trial NCT07571538?
This trial is currently recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2025-10-10. Estimated completion is 2026-08-01.
What interventions are being tested in trial NCT07571538?
The interventions under investigation include: Proclear 1 Day Contact Lens (DEVICE), MyDay Contact Lens (DEVICE), NaturalVue Contact Lens (DEVICE), MiSight 1 Day Contact Lens (DEVICE), Investigational Contact Lens (DEVICE).
Who is sponsoring clinical trial NCT07571538?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.